The DIAN Trials Unit (DIAN-TU) platform implements interventional therapeutic trials for at-risk families with DIAD, focusing on drugs that can potentially change the course of the disease.
Two types of DIAN-TU trials
The DIAN-TU site staff will determine which study is best suited for each potential participant, based on their estimated years to (symptom) onset, or “EYO”. A person’s EYO takes into consideration the actual age of the participant and the age at which their parent or relative became symptomatic.
Secondary Prevention Trials
These trials are studies aimed at stopping a disease from getting worse or causing further harm once it has already been detected.
Recent Publications
Optional feed….
DIAN-TU Support
Randall Bateman, MD
Principal Investigator & Program Director
- Phone: 314-286-1674
- Email: batemanr@wustl.edu
Study Team | Funding | History
Study details (DIAN-TU-001) on clinicaltrials.gov
For Investigators
Visit Investigator Resources for information on accessing resources and participation policies.